Medical Device News Magazine

Global Laboratory Proficiency Testing Market Report 2024: A $2.13 Billion Market by 2030, Expanding at a CAGR of 6.6% from 2024 to 2030

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Laboratory Proficiency Testing Market

The “Global Laboratory Proficiency Testing Market Size, Share & Trends Analysis Report by Industry (Clinical Diagnostics, Cannabis), Technology (Cell Culture, PCR), End-use (CROs, Hospitals), Region, and Segment Forecasts, 2024-2030″ report has been added to ResearchAndMarkets.com’s offering.

The global laboratory proficiency testing market size is expected to reach USD 2.13 billion by 2030, expanding at a CAGR of 6.6% from 2024 to 2030.

End-use industries, such as healthcare, environmental, food, and pharmaceuticals, are subject to strict regulatory requirements and accreditation standards, which is anticipated to drive the demand for laboratory proficiency testing in the coming years.

Moreover, participating in proficiency testing programs helps laboratories demonstrate compliance with these standards and regulatory bodies, ensuring the accuracy and reliability of their evaluating procedures, thereby contributing to the growth of the overall market.

Laboratory Proficiency Testing Market Report Highlights

  • Based on industry, the clinical diagnostic segment held the largest revenue share in 2023 due to the widespread adoption of proficiency testing to keep clinical diagnostic test results reliable and high-quality
  • The cell culture technology segment held the largest revenue share in 2023 owing to its wide usage in identifying contagious microorganisms in different applications
  • The hospitals end-use segment dominated the market in 2023. However, the contract research organizations (CROs) segment is expected to register the fastest CAGR from 2024 to 2030 due to the increasing demand for outsourcing services in the healthcare sector
  • North America held the largest share of 43.78% in 2023 due to the presence of well-established players, developed pharmaceutical & diagnostics industries, and high adoption of laboratory proficiency test
  • Key players operating in the market constantly focus on product launches, partnerships, and geographical expansions to maintain their industry position

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Industry and Technology Snapshot
2.3. End-use Snapshot
2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing Focus on Water Testing
3.4.2. Legalization of Medical Cannabis and Growing Number of Cannabis Testing Laboratories
3.4.3. Increase in Outbreaks of Foodborne Illnesses
3.5. Market Restraint Analysis
3.5.1. High Capital Investment for Laboratory Proficiency Testing
3.6. Industry Analysis Tools
3.7. Market Opportunity Analysis, by Industry
3.7.1. Clinical Diagnostics
3.7.2. Pharmaceuticals
3.7.3. Microbiology
3.7.4. Cannabis
3.7.5. Others

Chapter 4. Industry Business Analysis
4.1. Laboratory Proficiency Testing Market: Industry Movement Analysis
4.2. Clinical Diagnostics
4.2.2. Clinical Chemistry
4.2.3. Immunochemistry
4.2.4. Hematology
4.2.5. Oncology
4.2.6. Molecular Diagnostics
4.2.6.2. PCR
4.2.6.3. Others
4.2.7. Coagulation
4.3. Pharmaceuticals
4.3.2. Biological Products
4.3.2.2. Vaccines
4.3.2.3. Blood
4.3.2.4. Tissues
4.4. Microbiology
4.4.2. Pathogen Testing
4.4.3. Sterility Testing
4.4.4. Endotoxin & Pyrogen Testing
4.4.5. Growth Promotion Testing
4.5. Cannabis
4.5.2. Medical
4.5.3. Non-Medical

Chapter 5. Technology Business Analysis
5.1. Laboratory Proficiency Testing Market: Technology Movement Analysis
5.2. Cell Culture
5.3. Spectrometry
5.4. Polymerase Chain Reaction
5.5. Chromatography
5.6. Immunoassays

Chapter 6. End-use Business Analysis
6.1. Laboratory Proficiency Testing Market: End-use Movement Analysis
6.2. Hospitals
6.3. Contract Research Organizations
6.4. Pharmaceutical & Biotechnology Companies
6.5. Academic & Research Institutes
6.6. Laboratories
6.6.2. Independent Laboratories
6.6.3. Specialty Laboratories

Chapter 7. Regional Business Analysis

Chapter 8. Competitive Landscape

  • LGC
  • Bio-Rad Laboratories, Inc
  • Randox Laboratories
  • QACS – The Challenge Test Laboratory
  • Merck KGaA
  • Weqas
  • BIPEA
  • NSI Lab Solutions
  • Absolute Standards, Inc.
  • INSTAND

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”